Cerevel Therapeutics Holdings (CERE) stock forecast for 2022 – 2027

Are you interested in Cerevel Therapeutics Holdings, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CERE stock price in 2022-2027. Is CERE a good long term stock? When should I take profit in Cerevel Therapeutics Holdings stock? Buy or sell stock? Will CERE stock price go up? What are analysts’ forecasts for CERE stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. CERE stock returns are also predicted based on historical data.

According to our research, CERE stock is a awesome long-term investment. CERE share price has been in a positive cycle for the past year. Cerevel Therapeutics Holdings, Inc. stock trend is positive.

Cerevel Therapeutics Holdings company info

Industry Biotechnology
Address 222 Jacobs Street, Cambridge, MA, 02141, United States
Website https://www.cerevel.com

Forecasting

52 Week High: 49.6567 USD
52 Week Low: 25.6974 USD
1 Year Forecast: 50.0942 USD
5 Year Forecast: 140.484 USD

Agilent Technologies info

Market Cap: 3.83B
52 Week Change: 12.852%
52 Week High: 46.16 USD
52 Week Low: 12.01 USD
Beta: 1.33129
50 Day Moving Average: 29.74
90 Day Moving Average: 32.596
200 Day Moving Average: 31.67
Resistance Level: 27.733
Pivot Point: 25.3113
Support Level: 24.3097
Enterprise Value: 4,170,573,056
Forward P/E: -13.35
Forward EPS: -1.78
Profit Margin: 0.00%
Shares Outstanding: 147,236,000
EBITDA: -22.21
Held Percent Institutions: 81.90%
PEG Ratio (5Y): 0
Trailing EPS: -1.54

Cerevel Therapeutics Holdings stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Cerevel Therapeutics Holdings Stock Forecast for 2022

March 2022 28 30 7.14%
April 2022 29 30.69 5.83%
May 2022 31.31 32.67 4.34%
June 2022 32.34 34.65 7.14%
July 2022 35 36.63 4.66%
August 2022 37.74 38.61 2.31%
September 2022 38.22 40.18 5.13%
October 2022 40.59 42.14 3.82%
November 2022 42.57 45.9 7.82%
December 2022 45.9 46.53 1.37%

Cerevel Therapeutics Holdings Stock Forecast for 2023

January 2023 47 49.49 5.3%
February 2023 49 49.98 2%
March 2023 51.51 53.53 3.92%
April 2023 53.53 54.54 1.89%
May 2023 55.55 56 0.81%
June 2023 55.86 58 3.83%
July 2023 57.82 60 3.77%
August 2023 60.6 62 2.31%
September 2023 62 65.28 5.29%
October 2023 63.36 65.34 3.13%
November 2023 64.68 66.64 3.03%
December 2023 66.64 69.3 3.99%

Cerevel Therapeutics Holdings Stock Forecast for 2024

January 2024 70 71.28 1.83%
February 2024 71.28 73.26 2.78%
March 2024 75.48 76 0.69%
April 2024 74.48 78.78 5.77%
May 2024 78.78 80.8 2.56%
June 2024 81.6 83.64 2.5%
July 2024 82 84 2.44%
August 2024 83.16 86.86 4.45%
September 2024 86 88 2.33%
October 2024 86.24 90 4.36%
November 2024 90.9 89.18 -1.89%
December 2024 92.92 93 0.09%

Cerevel Therapeutics Holdings Stock Forecast for 2025

January 2025 92.07 95.95 4.21%
February 2025 96 95.06 -0.98%
March 2025 97 100.98 4.1%
April 2025 100.98 98.98 -1.98%
May 2025 102.01 104.03 1.98%
June 2025 100.94 103.95 2.98%
July 2025 106.05 105.93 -0.11%
August 2025 109.14 109 -0.13%
September 2025 109 108.78 -0.2%
October 2025 111 114.13 2.82%
November 2025 113 117.3 3.81%
December 2025 112.7 114.66 1.74%

Cerevel Therapeutics Holdings Stock Forecast for 2026

January 2026 119.34 119 -0.28%
February 2026 120.19 117.6 -2.15%
March 2026 122.4 119.56 -2.32%
April 2026 122 124 1.64%
May 2026 126.48 128.52 1.61%
June 2026 128.52 129.28 0.59%
July 2026 130.56 127.4 -2.42%
August 2026 131.3 133.32 1.54%
September 2026 134.64 136.68 1.52%
October 2026 135.34 138.72 2.5%
November 2026 133.28 136.62 2.51%
December 2026 138 142.8 3.48%

Cerevel Therapeutics Holdings Stock Forecast for 2027

January 2027 142.8 139.59 -2.25%